Is this the begining of the FDA and Big Pharma turning our own stem cells into drugs?

B

barbara

Pioneer Founding member
No. What Biologics is doing is coordinating and managing inventory of Neupogen (G-CSF). This is used routinely by many clinics pre-treatment. I had a series of 5 injections of it over a 5 day period before my last treatment. It must be kept very cold (I keep mine in the freezer when I use it) and this company sounds like they have found a niche to supply and coordinate the delivery of about 200 shipments per month of the product which should keep them busy.
 
H

hlichten

Super Moderator
barbara said:
No. What Biologics is doing is coordinating and managing inventory of Neupogen (G-CSF). This is used routinely by many clinics pre-treatment. I had a series of 5 injections of it over a 5 day period before my last treatment. It must be kept very cold (I keep mine in the freezer when I use it) and this company sounds like they have found a niche to supply and coordinate the delivery of about 200 shipments per month of the product which should keep them busy.
Click to expand...
Barbara:
Was Mozobil added to the Neupogen you used?
Just wondering, since I had previously seen this article:
http://www.myelomabeacon.com/news/2009/05/13/mozobil-with-neupogen-increases-stem-cell-harvest-efficiency/

I sure wish that I had used some of these injections before my autologous treatments.
 
B

barbara

Pioneer Founding member
I checked the box and it is made by Merck in Italy. I can't see anything that remotely looks like the word Mozobil however. I don't read Italian, but I think I could figure it out if it was an ingredient.

I have had G-CSF administered on my last 3 treatments. I am told it is somewhat costly so perhaps some doctors don't use it for that reason, however, with what is being charged for stem cell treatments, I think it should be included. This would be a good question for people to ask when researching treatment options.
 
You must log in or register to reply here.
Top